API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.prnewswire.com/news-releases/harmony-biosciences-initiates-global-phase-3-registrational-trial-tempo-study-of-pitolisant-in-patients-with-prader-willi-syndrome-302106423.html
https://www.prnewswire.com/news-releases/harmony-biosciences-receives-us-food-and-drug-administration-orphan-drug-designation-for-pitolisant-in-prader-willi-syndrome-302065480.html
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-positive-topline-data-from-phase-2-signal-detection-study-evaluating-pitolisant-in-adult-patients-with-myotonic-dystrophy-type-1-302008352.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-pitolisant-hydrochloride-tablets-47857.pdf
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-topline-data-from-phase-3-intune-study-evaluating-pitolisant-in-patients-with-idiopathic-hypersomnia-301955736.html
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-us-food--drug-administration-orphan-drug-designation-for-pitolisant-for-treatment-of-idiopathic-hypersomnia-301920012.html
https://www.prnewswire.com/news-releases/harmony-biosciences-reiterates-confidence-in-wakix-pitolisant-patents-following-favorable-decision-by-us-patent-and-trademark-office-uspto-to-deny-petition-for-reexamination-301910704.html
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-plans-to-initiate-phase-3-registrational-study-of-pitolisant-in-prader-willi-syndrome-following-positive-end-of-phase-2-meeting-with-the-us-food-and-drug-administration-301881691.html
https://www.prnewswire.com/news-releases/china-nmpa-approves-rarestones-pitolisant-wakix-for-the-treatment-of-narcolepsy-301869589.html
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-positive-phase-2-signal-detection-study-evaluating-pitolisant-for-excessive-daytime-sleepiness-in-prader-willi-syndrome-at-sleep-2023-301842901.html
https://www.prnewswire.com/news-releases/bioprojet-wakix-pitolisant-receives-approval-for-the-treatment-of-narcolepsy-in-children-over-6-years-of-age-a-rare-under-diagnosed-condition-301772642.html
https://www.clinicaltrialsarena.com/news/harmony-prader-willi-syndrome-trial/
https://www.harmonybiosciences.com/newsroom/harmony-biosciences-reports-second-quarter-2022-financial-results-and-business-updates
https://www.prnewswire.com/news-releases/harmony-biosciences-presents-post-hoc-analysis-of-wakix-pitolisant-pivotal-data-in-adults-with-high-burden-of-narcolepsy-symptoms-301561134.html
https://www.clinicaltrialsarena.com/news/harmony-idiopathic-hypersomnia-trial/
http://www.pharmatimes.com/news/ema_nod_for_excessive_daytime_sleepiness_med_ozawade_1382343
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-inclusion-of-wakix-pitolisant-in-american-academy-of-sleep-medicines-updated-clinical-practice-guideline-301367958.html
https://www.prnewswire.com/news-releases/harmony-biosciences-to-present-wakix-pitolisant-efficacy-and-safety-data-at-upcoming-2021-american-psychiatric-association-annual-meeting-301276982.html
https://www.prnewswire.com/news-releases/harmony-biosciences-to-present-wakix-pitolisant-efficacy-and-safety-data-at-upcoming-2021-american-psychiatric-association-annual-meeting-301276982.html
https://www.prnewswire.com/news-releases/harmony-biosciences-to-present-wakix-pitolisant-data-at-the-2021-aan-annual-meeting-301266363.html
https://www.prnewswire.com/news-releases/harmony-biosciences-to-present-wakix-pitolisant-data-at-the-2021-aan-annual-meeting-301266363.html
https://www.raps.org/news-and-articles/news-articles/2020/10/fda-approvals-roundup-inmazeb-wakix-venclexta
https://pharmaphorum.com/news/harmonys-narcolepsy-drug-gets-extended-cataplexy/#:~:text=Harmony%20Biosciences%20has%20scored%20an,sleepiness%20in%20adults%20with%20narcolepsy.
https://www.prnewswire.com/news-releases/harmony-biosciences-presents-efficacy-and-safety-analyses-for-wakix-pitolisant-at-virtual-sleep-2020-301120099.html
https://www.prnewswire.com/news-releases/harmony-biosciences-to-present-new-data-for-wakix-pitolisant-at-sleep-2020-annual-meeting-301116567.html
https://www.prnewswire.com/news-releases/harmony-biosciences-to-present-new-data-for-wakix-pitolisant-at-sleep-2020-annual-meeting-301116567.html
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193861/#:~:text=Conclusions%3A%20Pitolisant%20significantly%20reduced%20self,to%20continuous%20positive%20airway%20pressure.
https://www.prnewswire.com/news-releases/wakix-pitolisant-data-from-harmony-biosciences-included-on-american-academy-of-neurology-science-highlights-virtual-platform-301068604.html
https://endpts.com/ex-biotech-chief-pleads-guilty-in-college-admissions-scandal-faces-a-10-month-prison-stretch-in-plea-deal/
https://www.biospectrumasia.com/analysis/25/14270/following-fda-approval-wakix-will-gain-a-small-share-in-narcolepsy-market-.html
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-fda-approval-of-wakix-pitolisant-a-first-in-class-medication-for-the-treatment-of-excessive-daytime-sleepiness-in-adult-patients-with-narcolepsy-300902091.html
https://www.fiercepharma.com/pharma/500m-financing-harmony-scores-first-approval-narcolepsy-med-wakix
https://www.biospace.com/article/harmony-biosciences-makes-headway-on-narcolepsy-drug-involving-histamine/
http://www.raredr.com/news/narcolepsy-treatment-pitolisant-receives-fda-fast-track-designation